The Legal Examiner Affiliate Network The Legal Examiner The Legal Examiner The Legal Examiner search feed instagram google-plus avvo phone envelope checkmark mail-reply spinner error close The Legal Examiner The Legal Examiner The Legal Examiner
Skip to main content
| Dr. Shezad Malik Law Firm

Breast Implants linked to Lymphoma cancer. According to several medical experts and reports, there is an increased risk of lymphoma cancer from artificial breast implants.

Breast Lymphoma Cancer after Breast Implant attorney
FDA warning breast lymphoma cancer linked to breast implants

Breast Implants is big business in U.S.

According to the American Society of Plastic Surgeons around 550,000 women received breast implants in 2016 in the United States.

FDA Warning 359 cancer cases with 9 Deaths

Recently the U.S. Food and Drug Administration (FDA) and health agencies in other countries, warned that some types of artificial breast implants are linked to a rare form of cancer known as anaplastic large cell lymphoma (ALCL).

The FDA highlighted the breast implant lymphoma risks in a March 2017 update, noting that the agency was aware of at least 359 medical device reports involving women diagnosed with the sub-type of non-Hodgkins lymphoma, and at least nine deaths.

The cancer is now commonly referred to as breast implant-associated anaplastic large cell lymphoma (BIA-ALCL).

Australia’s Therapeutic Goods Administration (TGA) health agency began to monitor for cases of breast implant-associated anaplastic large cell lymphoma earlier this year. The number of identified cases in Australia has more than doubled as a result of this targeted focus.

What is BIA-ALCL?

BIA-ALCL is not breast cancer. According to the World Health Organization, BIA-ALCL is a rare T-cell lymphoma that can develop following breast implants.

The FDA agrees with the World Health Organization that BIA-ALCL is a rare T-cell lymphoma that can develop following breast implants.

At this time, most data suggest that BIA-ALCL occurs more frequently following implantation of breast implants with textured surfaces rather than those with smooth surfaces.

The FDA first identified a possible association between breast implants and the development of ALCL in 2011. At that time, the FDA knew of so few cases of this disease that it was not possible to determine what factors increased the risk.

Textured breasts have a higher risk of cancer

Investigators have discovered that the breast implant cancer cases occur more frequently among women who received textured surface implants.

It is thought that the textured surfaces may be causing chronic inflammation and immune system reactions, leading to the development of lymphoma in the fluid around the breast implant.

The Dr. Shezad Malik Law Firm is currently reviewing potential breast implant cancer lawsuits for women diagnosed with this rare lymphoma that develops in the tissue surrounding the implant.


Comments for this article are closed, but you may still contact the author privately.